Researchers developing benchmarks for a blood-based test like those for measuring blood glucose and cholesterol ...

There's new research linking senolytics to helping slow down Alzheimer's progression. Here's how and what experts have to say ...

Roche’s Brainshuttle tech shows promise in Alzheimer’s treatment, enabling better drug delivery to the brain in trials.

US-based Alzheon’s Alzheimer’s disease pill has failed in a Phase III trial, but the biopharma still holds hope for the drug ...

CERN’s LHCb experiment confirms CP violation in baryons, marking a milestone in particle physics; Japan unveils the world’s ...

Ultrasound therapy is emerging as a potential treatment for Alzheimer’s disease. It uses ultrasound to open the blood-brain ...

Some neurologists and a consumer watchdog worry that an Eli Lilly–affiliated direct-to-consumer telehealth platform for Alzheimer’s could lead to misdiagnosis or unnecessary treatment.

An extended study after a primary trial supports using the anti-amyloid drug lecanemab (Leqembi) for up to 36 months in ...

According to the authors, the research opens up new possibilities for developing the next generation of ChE inhibitors that ...